

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | intestinal cholesterol absorption (GO:0030299) | 9.87938856 |
| 2 | angiotensin maturation (GO:0002003) | 8.98100659 |
| 3 | vitamin A metabolic process (GO:0006776) | 6.23171553 |
| 4 | flavonoid metabolic process (GO:0009812) | 5.95542584 |
| 5 | actin filament depolymerization (GO:0030042) | 5.91950884 |
| 6 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 5.90420533 |
| 7 | cellular glucuronidation (GO:0052695) | 5.83250318 |
| 8 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 5.79597800 |
| 9 | uronic acid metabolic process (GO:0006063) | 5.62406610 |
| 10 | glucuronate metabolic process (GO:0019585) | 5.62406610 |
| 11 | digestive system process (GO:0022600) | 5.57365712 |
| 12 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 5.55094325 |
| 13 | intestinal epithelial cell development (GO:0060576) | 5.49808740 |
| 14 | regulation of respiratory burst (GO:0060263) | 5.49197290 |
| 15 | maintenance of gastrointestinal epithelium (GO:0030277) | 5.42561591 |
| 16 | positive regulation of respiratory burst (GO:0060267) | 5.35639575 |
| 17 | regulation of bile acid biosynthetic process (GO:0070857) | 5.35280284 |
| 18 | virion attachment to host cell (GO:0019062) | 5.09773789 |
| 19 | adhesion of symbiont to host cell (GO:0044650) | 5.09773789 |
| 20 | drug catabolic process (GO:0042737) | 4.89826457 |
| 21 | epoxygenase P450 pathway (GO:0019373) | 4.81608792 |
| 22 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 4.80672454 |
| 23 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 4.80672454 |
| 24 | sulfation (GO:0051923) | 4.76837595 |
| 25 | positive regulation of guanylate cyclase activity (GO:0031284) | 4.70371985 |
| 26 | bile acid and bile salt transport (GO:0015721) | 4.68336626 |
| 27 | phospholipid efflux (GO:0033700) | 4.45088128 |
| 28 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.44094811 |
| 29 | modified amino acid transport (GO:0072337) | 4.33329895 |
| 30 | ethanol oxidation (GO:0006069) | 4.33125611 |
| 31 | positive regulation of triglyceride lipase activity (GO:0061365) | 4.32391811 |
| 32 | positive regulation of lipoprotein lipase activity (GO:0051006) | 4.32391811 |
| 33 | NADH metabolic process (GO:0006734) | 4.27749170 |
| 34 | glucose 6-phosphate metabolic process (GO:0051156) | 4.26508276 |
| 35 | response to hepatocyte growth factor (GO:0035728) | 4.26334081 |
| 36 | cellular response to hepatocyte growth factor stimulus (GO:0035729) | 4.26334081 |
| 37 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 4.26240146 |
| 38 | regulation of cellular extravasation (GO:0002691) | 4.24650101 |
| 39 | renal system process involved in regulation of blood volume (GO:0001977) | 4.23575565 |
| 40 | drug metabolic process (GO:0017144) | 4.22418126 |
| 41 | negative regulation of epidermal cell differentiation (GO:0045605) | 4.20533671 |
| 42 | antibacterial humoral response (GO:0019731) | 4.18314023 |
| 43 | regulation of cGMP biosynthetic process (GO:0030826) | 4.18116625 |
| 44 | digestion (GO:0007586) | 4.16211018 |
| 45 | oligosaccharide biosynthetic process (GO:0009312) | 4.13009230 |
| 46 | regulation of cholesterol esterification (GO:0010872) | 4.12502239 |
| 47 | glomerular filtration (GO:0003094) | 4.09831636 |
| 48 | regulation of triglyceride catabolic process (GO:0010896) | 4.09564923 |
| 49 | sulfate transmembrane transport (GO:1902358) | 4.09409010 |
| 50 | antimicrobial humoral response (GO:0019730) | 4.09356441 |
| 51 | fat-soluble vitamin biosynthetic process (GO:0042362) | 4.04585471 |
| 52 | epithelial structure maintenance (GO:0010669) | 4.01585648 |
| 53 | adhesion of symbiont to host (GO:0044406) | 4.00413174 |
| 54 | lipoprotein metabolic process (GO:0042157) | 3.99326830 |
| 55 | plasma lipoprotein particle assembly (GO:0034377) | 3.98646045 |
| 56 | positive regulation of pseudopodium assembly (GO:0031274) | 3.95614262 |
| 57 | alkaloid metabolic process (GO:0009820) | 3.93745179 |
| 58 | arginine metabolic process (GO:0006525) | 3.93130852 |
| 59 | O-glycan processing (GO:0016266) | 3.93064052 |
| 60 | regulation of systemic arterial blood pressure (GO:0003073) | 3.87987934 |
| 61 | protein-lipid complex assembly (GO:0065005) | 3.85192540 |
| 62 | renal filtration (GO:0097205) | 3.80592695 |
| 63 | lung secretory cell differentiation (GO:0061140) | 3.79620704 |
| 64 | thyroid hormone metabolic process (GO:0042403) | 3.78412114 |
| 65 | drug transmembrane transport (GO:0006855) | 3.76107370 |
| 66 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.74870594 |
| 67 | sulfur compound transport (GO:0072348) | 3.71715214 |
| 68 | urea cycle (GO:0000050) | 3.69249392 |
| 69 | regulation of cholesterol homeostasis (GO:2000188) | 3.68375473 |
| 70 | GDP-mannose metabolic process (GO:0019673) | 3.67569996 |
| 71 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.65340629 |
| 72 | desmosome organization (GO:0002934) | 3.65206400 |
| 73 | complement activation, classical pathway (GO:0006958) | 3.65076851 |
| 74 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.65040009 |
| 75 | urea metabolic process (GO:0019627) | 3.62705992 |
| 76 | ethanol metabolic process (GO:0006067) | 3.60515686 |
| 77 | auditory receptor cell differentiation (GO:0042491) | 3.55515300 |
| 78 | diacylglycerol metabolic process (GO:0046339) | 3.54295744 |
| 79 | regulation of vitamin metabolic process (GO:0030656) | 3.53954583 |
| 80 | regulation of actin nucleation (GO:0051125) | 3.53816185 |
| 81 | bicarbonate transport (GO:0015701) | 3.53153800 |
| 82 | regulation of pseudopodium assembly (GO:0031272) | 3.52590319 |
| 83 | vitamin transmembrane transport (GO:0035461) | 3.51728878 |
| 84 | cellular response to pH (GO:0071467) | 3.49391711 |
| 85 | hepatocyte apoptotic process (GO:0097284) | 3.48549765 |
| 86 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.47668710 |
| 87 | drug transport (GO:0015893) | 3.47326523 |
| 88 | hemidesmosome assembly (GO:0031581) | 3.47255737 |
| 89 | hormone catabolic process (GO:0042447) | 3.46670071 |
| 90 | purine nucleotide salvage (GO:0032261) | 3.45864407 |
| 91 | transcytosis (GO:0045056) | 3.44707768 |
| 92 | cholesterol efflux (GO:0033344) | 3.44697591 |
| 93 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.42918433 |
| 94 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.40935417 |
| 95 | arginine catabolic process (GO:0006527) | 3.40860059 |
| 96 | fucosylation (GO:0036065) | 3.40260366 |
| 97 | peptide hormone processing (GO:0016486) | 3.39103904 |
| 98 | regulation of cGMP metabolic process (GO:0030823) | 3.38979621 |
| 99 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.35976554 |
| 100 | sulfate transport (GO:0008272) | 3.34727448 |
| 101 | nitrogen cycle metabolic process (GO:0071941) | 3.33468833 |
| 102 | cytidine deamination (GO:0009972) | 3.33439071 |
| 103 | cytidine metabolic process (GO:0046087) | 3.33439071 |
| 104 | cytidine catabolic process (GO:0006216) | 3.33439071 |
| 105 | phenylpropanoid metabolic process (GO:0009698) | 3.30774659 |
| 106 | transepithelial transport (GO:0070633) | 3.30495308 |
| 107 | defense response to fungus (GO:0050832) | 3.30451535 |
| 108 | sperm capacitation (GO:0048240) | 3.30391254 |
| 109 | cholesterol homeostasis (GO:0042632) | 3.30318479 |
| 110 | exogenous drug catabolic process (GO:0042738) | 3.28807482 |
| 111 | sterol homeostasis (GO:0055092) | 3.28266985 |
| 112 | disruption of cells of other organism (GO:0044364) | 3.27065935 |
| 113 | killing of cells of other organism (GO:0031640) | 3.27065935 |
| 114 | negative regulation of sterol transport (GO:0032372) | 3.27060503 |
| 115 | negative regulation of cholesterol transport (GO:0032375) | 3.27060503 |
| 116 | drinking behavior (GO:0042756) | 3.25912455 |
| 117 | oligosaccharide catabolic process (GO:0009313) | 3.25821472 |
| 118 | lipoprotein transport (GO:0042953) | 3.25688513 |
| 119 | cGMP-mediated signaling (GO:0019934) | 3.25317545 |
| 120 | thrombin receptor signaling pathway (GO:0070493) | 3.23540336 |
| 121 | bile acid metabolic process (GO:0008206) | 3.20597721 |
| 122 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 3.18485080 |
| 123 | plasma lipoprotein particle remodeling (GO:0034369) | 3.17747105 |
| 124 | protein-lipid complex remodeling (GO:0034368) | 3.17747105 |
| 125 | macromolecular complex remodeling (GO:0034367) | 3.17747105 |
| 126 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 3.16350271 |
| 127 | glucocorticoid biosynthetic process (GO:0006704) | 3.15068391 |
| 128 | sodium ion homeostasis (GO:0055078) | 3.14128895 |
| 129 | mucosal immune response (GO:0002385) | 3.13289086 |
| 130 | cholesterol transport (GO:0030301) | 3.13281397 |
| 131 | sterol transport (GO:0015918) | 3.13281397 |
| 132 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 3.12334186 |
| 133 | positive regulation of fatty acid oxidation (GO:0046321) | 3.11248935 |
| 134 | proline biosynthetic process (GO:0006561) | 3.10707077 |
| 135 | negative regulation of keratinocyte proliferation (GO:0010839) | 3.09748135 |
| 136 | peptide catabolic process (GO:0043171) | 3.09427847 |
| 137 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.08620475 |
| 138 | glycerol metabolic process (GO:0006071) | 3.07517895 |
| 139 | regulation of keratinocyte proliferation (GO:0010837) | 3.06198521 |
| 140 | endocrine process (GO:0050886) | 3.04074519 |
| 141 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 3.04074519 |
| 142 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 3.04074519 |
| 143 | regulation of guanylate cyclase activity (GO:0031282) | 3.04073544 |
| 144 | negative regulation of myotube differentiation (GO:0010832) | 3.03728543 |
| 145 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.03544796 |
| 146 | positive regulation of lipid catabolic process (GO:0050996) | 3.01153725 |
| 147 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.00634871 |
| 148 | negative regulation of epidermis development (GO:0045683) | 2.98343205 |
| 149 | fucose catabolic process (GO:0019317) | 2.98087166 |
| 150 | L-fucose metabolic process (GO:0042354) | 2.98087166 |
| 151 | L-fucose catabolic process (GO:0042355) | 2.98087166 |
| 152 | hydrogen peroxide metabolic process (GO:0042743) | 2.97447280 |
| 153 | striated muscle atrophy (GO:0014891) | 2.97069043 |
| 154 | fructose metabolic process (GO:0006000) | 2.96961731 |
| 155 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.95937824 |
| 156 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.95148721 |
| 157 | organ or tissue specific immune response (GO:0002251) | 2.94830722 |
| 158 | innate immune response in mucosa (GO:0002227) | 2.94084065 |
| 159 | sulfur amino acid catabolic process (GO:0000098) | 2.93899858 |
| 160 | plasma lipoprotein particle organization (GO:0071827) | 2.91014817 |
| 161 | positive regulation of cGMP biosynthetic process (GO:0030828) | 2.89936506 |
| 162 | intestinal absorption (GO:0050892) | 11.1339586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 9.48638169 |
| 2 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 5.76744487 |
| 3 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 3.86143995 |
| 4 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 3.31925970 |
| 5 | GATA4_25053715_ChIP-Seq_YYC3_Human | 3.11271989 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.07522779 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 3.01293213 |
| 8 | * SOX2_20726797_ChIP-Seq_SW620_Human | 2.98312443 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.96822323 |
| 10 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 2.86572121 |
| 11 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.74943417 |
| 12 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.70656974 |
| 13 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.56777451 |
| 14 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.14656198 |
| 15 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13924567 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.03093377 |
| 17 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 2.02746763 |
| 18 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.02513531 |
| 19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.01934264 |
| 20 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.01653490 |
| 21 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.00846465 |
| 22 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.98033560 |
| 23 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.91110196 |
| 24 | * KLF5_25053715_ChIP-Seq_YYC3_Human | 1.80765772 |
| 25 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.78606722 |
| 26 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.71795330 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.70716499 |
| 28 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.59683692 |
| 29 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.57758266 |
| 30 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54756455 |
| 31 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54576435 |
| 32 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.52774842 |
| 33 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.52539679 |
| 34 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.52166725 |
| 35 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.51904328 |
| 36 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.49472701 |
| 37 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.48376772 |
| 38 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.48240678 |
| 39 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48240574 |
| 40 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42689166 |
| 41 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.42088483 |
| 42 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.38544882 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.37270287 |
| 44 | GATA1_26923725_Chip-Seq_HPCs_Mouse | 1.35408855 |
| 45 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.34869444 |
| 46 | CEBPB_22108803_ChIP-Seq_LS180_Human | 1.32123214 |
| 47 | ATF3_27146783_Chip-Seq_COLON_Human | 1.30933695 |
| 48 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.29204899 |
| 49 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.28733630 |
| 50 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.27770205 |
| 51 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.23474991 |
| 52 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23086219 |
| 53 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.23054532 |
| 54 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.22892869 |
| 55 | VDR_22108803_ChIP-Seq_LS180_Human | 1.21165950 |
| 56 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.14425091 |
| 57 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.13435297 |
| 58 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12813151 |
| 59 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.10650451 |
| 60 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.09122889 |
| 61 | SA1_27219007_Chip-Seq_Bcells_Human | 1.07182527 |
| 62 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05396102 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.05283540 |
| 64 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.05165623 |
| 65 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.02810919 |
| 66 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.01048585 |
| 67 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.00281462 |
| 68 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.00138032 |
| 69 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.00091710 |
| 70 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.98793047 |
| 71 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.98638738 |
| 72 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.98527330 |
| 73 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.97789320 |
| 74 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.97721773 |
| 75 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96693290 |
| 76 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.95119478 |
| 77 | * TP63_22573176_ChIP-Seq_HFKS_Human | 0.95118014 |
| 78 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.95024140 |
| 79 | TP53_16413492_ChIP-PET_HCT116_Human | 0.94467471 |
| 80 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.93776825 |
| 81 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92953306 |
| 82 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92760671 |
| 83 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92744394 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92744394 |
| 85 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92622017 |
| 86 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92337734 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.92295001 |
| 88 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.92187425 |
| 89 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.91876206 |
| 90 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.91029895 |
| 91 | * ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90457960 |
| 92 | P300_27268052_Chip-Seq_Bcells_Human | 0.90383788 |
| 93 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.89941087 |
| 94 | * EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.89918461 |
| 95 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.88994596 |
| 96 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.88900718 |
| 97 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.88627435 |
| 98 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.87245653 |
| 99 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.86912283 |
| 100 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.86450005 |
| 101 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.85561509 |
| 102 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.84645956 |
| 103 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83902152 |
| 104 | P68_20966046_ChIP-Seq_HELA_Human | 0.83169190 |
| 105 | PHF8_20622854_ChIP-Seq_HELA_Human | 0.83059070 |
| 106 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.82859257 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82620103 |
| 108 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.82339050 |
| 109 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82016749 |
| 110 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.82015254 |
| 111 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81881668 |
| 112 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.81660375 |
| 113 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.80369404 |
| 114 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.80122557 |
| 115 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.79953735 |
| 116 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.79083238 |
| 117 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.78543948 |
| 118 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.78177423 |
| 119 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77137353 |
| 120 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76605543 |
| 121 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.76369479 |
| 122 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75705745 |
| 123 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.75432438 |
| 124 | GATA1_19941826_ChIP-Seq_K562_Human | 0.75174417 |
| 125 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.74731887 |
| 126 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.74405634 |
| 127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.74217914 |
| 128 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.72198271 |
| 129 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.70671789 |
| 130 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.70602433 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 8.17844964 |
| 2 | MP0009840_abnormal_foam_cell | 5.52047042 |
| 3 | MP0001666_abnormal_nutrient_absorption | 5.33093247 |
| 4 | MP0010234_abnormal_vibrissa_follicle | 4.56393740 |
| 5 | MP0000462_abnormal_digestive_system | 4.41711343 |
| 6 | MP0004264_abnormal_extraembryonic_tissu | 3.79154574 |
| 7 | MP0003866_abnormal_defecation | 3.37613038 |
| 8 | MP0005085_abnormal_gallbladder_physiolo | 3.13826213 |
| 9 | MP0002138_abnormal_hepatobiliary_system | 3.12049944 |
| 10 | MP0002139_abnormal_hepatobiliary_system | 2.94045576 |
| 11 | MP0003183_abnormal_peptide_metabolism | 2.81407911 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68033386 |
| 13 | MP0003252_abnormal_bile_duct | 2.56622049 |
| 14 | MP0005381_digestive/alimentary_phenotyp | 2.53940090 |
| 15 | MP0001873_stomach_inflammation | 2.45479867 |
| 16 | MP0010155_abnormal_intestine_physiology | 2.41049692 |
| 17 | MP0001663_abnormal_digestive_system | 2.39445174 |
| 18 | MP0002822_catalepsy | 2.23953892 |
| 19 | MP0000490_abnormal_crypts_of | 2.23755713 |
| 20 | MP0000477_abnormal_intestine_morphology | 1.99682951 |
| 21 | MP0005377_hearing/vestibular/ear_phenot | 1.98510939 |
| 22 | MP0003878_abnormal_ear_physiology | 1.98510939 |
| 23 | MP0010329_abnormal_lipoprotein_level | 1.96209927 |
| 24 | MP0009379_abnormal_foot_pigmentation | 1.92993903 |
| 25 | MP0000537_abnormal_urethra_morphology | 1.90425451 |
| 26 | MP0001664_abnormal_digestion | 1.86555912 |
| 27 | MP0002102_abnormal_ear_morphology | 1.82071974 |
| 28 | MP0004019_abnormal_vitamin_homeostasis | 1.81494261 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 1.80947849 |
| 30 | MP0000538_abnormal_urinary_bladder | 1.77059177 |
| 31 | MP0003705_abnormal_hypodermis_morpholog | 1.68116154 |
| 32 | MP0004147_increased_porphyrin_level | 1.62398229 |
| 33 | MP0005365_abnormal_bile_salt | 1.60983461 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.55356267 |
| 35 | MP0002796_impaired_skin_barrier | 1.51116090 |
| 36 | MP0000566_synostosis | 1.45788957 |
| 37 | MP0004043_abnormal_pH_regulation | 1.42320199 |
| 38 | MP0000465_gastrointestinal_hemorrhage | 1.41753775 |
| 39 | MP0005670_abnormal_white_adipose | 1.32684328 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.30530960 |
| 41 | MP0003191_abnormal_cellular_cholesterol | 1.28915272 |
| 42 | MP0005409_darkened_coat_color | 1.28839375 |
| 43 | MP0002166_altered_tumor_susceptibility | 1.28138909 |
| 44 | MP0003806_abnormal_nucleotide_metabolis | 1.20903174 |
| 45 | MP0005448_abnormal_energy_balance | 1.20567001 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 1.19773076 |
| 47 | MP0003315_abnormal_perineum_morphology | 1.17585610 |
| 48 | MP0003868_abnormal_feces_composition | 1.13497776 |
| 49 | MP0003724_increased_susceptibility_to | 1.13273109 |
| 50 | MP0002876_abnormal_thyroid_physiology | 1.08910382 |
| 51 | MP0001849_ear_inflammation | 1.08296781 |
| 52 | MP0006054_spinal_hemorrhage | 1.07433311 |
| 53 | MP0004947_skin_inflammation | 1.06413677 |
| 54 | MP0003283_abnormal_digestive_organ | 1.04433845 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.03108520 |
| 56 | MP0009643_abnormal_urine_homeostasis | 1.01812749 |
| 57 | MP0002006_tumorigenesis | 0.99088171 |
| 58 | MP0001756_abnormal_urination | 0.97798303 |
| 59 | MP0002277_abnormal_respiratory_mucosa | 0.95671960 |
| 60 | MP0000230_abnormal_systemic_arterial | 0.93064912 |
| 61 | MP0001188_hyperpigmentation | 0.92795074 |
| 62 | MP0010678_abnormal_skin_adnexa | 0.92462690 |
| 63 | MP0003718_maternal_effect | 0.90695544 |
| 64 | MP0005501_abnormal_skin_physiology | 0.89752249 |
| 65 | MP0001765_abnormal_ion_homeostasis | 0.89512104 |
| 66 | MP0002060_abnormal_skin_morphology | 0.89215223 |
| 67 | MP0008872_abnormal_physiological_respon | 0.88350727 |
| 68 | MP0001845_abnormal_inflammatory_respons | 0.87920024 |
| 69 | MP0002089_abnormal_postnatal_growth/wei | 0.85381991 |
| 70 | MP0001485_abnormal_pinna_reflex | 0.84937962 |
| 71 | MP0005166_decreased_susceptibility_to | 0.84825801 |
| 72 | MP0002254_reproductive_system_inflammat | 0.83392082 |
| 73 | MP0001216_abnormal_epidermal_layer | 0.80408626 |
| 74 | MP0003453_abnormal_keratinocyte_physiol | 0.80399839 |
| 75 | MP0003938_abnormal_ear_development | 0.79367167 |
| 76 | MP0005165_increased_susceptibility_to | 0.79025899 |
| 77 | MP0002118_abnormal_lipid_homeostasis | 0.77994436 |
| 78 | MP0003693_abnormal_embryo_hatching | 0.77297316 |
| 79 | MP0000467_abnormal_esophagus_morphology | 0.76396686 |
| 80 | MP0005451_abnormal_body_composition | 0.76187165 |
| 81 | MP0002971_abnormal_brown_adipose | 0.73125008 |
| 82 | MP0005636_abnormal_mineral_homeostasis | 0.72871819 |
| 83 | MP0005332_abnormal_amino_acid | 0.72533107 |
| 84 | MP0000377_abnormal_hair_follicle | 0.71854733 |
| 85 | MP0000609_abnormal_liver_physiology | 0.70956836 |
| 86 | MP0003879_abnormal_hair_cell | 0.70498650 |
| 87 | MP0009780_abnormal_chondrocyte_physiolo | 0.70490194 |
| 88 | MP0005025_abnormal_response_to | 0.70128538 |
| 89 | MP0005310_abnormal_salivary_gland | 0.68691300 |
| 90 | MP0002098_abnormal_vibrissa_morphology | 0.66927232 |
| 91 | MP0009697_abnormal_copulation | 0.65398632 |
| 92 | MP0004858_abnormal_nervous_system | 0.64232659 |
| 93 | MP0005535_abnormal_body_temperature | 0.62191861 |
| 94 | MP0000470_abnormal_stomach_morphology | 0.61350814 |
| 95 | MP0003045_fibrosis | 0.61274698 |
| 96 | MP0009642_abnormal_blood_homeostasis | 0.60291348 |
| 97 | MP0004782_abnormal_surfactant_physiolog | 0.60166651 |
| 98 | MP0003119_abnormal_digestive_system | 0.58744440 |
| 99 | MP0000678_abnormal_parathyroid_gland | 0.58412465 |
| 100 | MP0008469_abnormal_protein_level | 0.57966817 |
| 101 | MP0010771_integument_phenotype | 0.57352131 |
| 102 | MP0001835_abnormal_antigen_presentation | 0.57162224 |
| 103 | MP0002136_abnormal_kidney_physiology | 0.55902786 |
| 104 | MP0000015_abnormal_ear_pigmentation | 0.55432155 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.55431032 |
| 106 | MP0003953_abnormal_hormone_level | 0.54283229 |
| 107 | MP0005387_immune_system_phenotype | 0.54229684 |
| 108 | MP0001790_abnormal_immune_system | 0.54229684 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.53131128 |
| 110 | MP0004484_altered_response_of | 0.52985798 |
| 111 | MP0004270_analgesia | 0.51469084 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.51038012 |
| 113 | MP0000579_abnormal_nail_morphology | 0.50950022 |
| 114 | MP0009053_abnormal_anal_canal | 0.50123591 |
| 115 | MP0001764_abnormal_homeostasis | 0.49342799 |
| 116 | MP0009115_abnormal_fat_cell | 0.49252789 |
| 117 | MP0006082_CNS_inflammation | 0.47271788 |
| 118 | MP0009333_abnormal_splenocyte_physiolog | 0.47004272 |
| 119 | MP0008004_abnormal_stomach_pH | 0.45858801 |
| 120 | MP0009785_altered_susceptibility_to | 0.44338719 |
| 121 | MP0003656_abnormal_erythrocyte_physiolo | 0.43652387 |
| 122 | MP0003941_abnormal_skin_development | 0.43348766 |
| 123 | MP0005266_abnormal_metabolism | 0.43241680 |
| 124 | MP0003950_abnormal_plasma_membrane | 0.43134104 |
| 125 | MP0005023_abnormal_wound_healing | 0.43103364 |
| 126 | MP0008873_increased_physiological_sensi | 0.41691826 |
| 127 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.40313859 |
| 128 | MP0001501_abnormal_sleep_pattern | 0.40244135 |
| 129 | MP0000613_abnormal_salivary_gland | 0.40098721 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ileus (HP:0002595) | 9.30528142 |
| 2 | Decreased circulating renin level (HP:0003351) | 6.49718069 |
| 3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 6.16909485 |
| 4 | Right ventricular cardiomyopathy (HP:0011663) | 5.91658428 |
| 5 | Abnormality of renin-angiotensin system (HP:0000847) | 5.79688685 |
| 6 | Acanthocytosis (HP:0001927) | 5.50459686 |
| 7 | Malnutrition (HP:0004395) | 5.38944748 |
| 8 | Hypobetalipoproteinemia (HP:0003563) | 4.86044200 |
| 9 | Alkalosis (HP:0001948) | 4.83999342 |
| 10 | Abnormality of proline metabolism (HP:0010907) | 4.55637888 |
| 11 | Hydroxyprolinuria (HP:0003080) | 4.55637888 |
| 12 | Conjugated hyperbilirubinemia (HP:0002908) | 4.50427319 |
| 13 | Cupped ribs (HP:0000887) | 4.19819958 |
| 14 | Hyperaldosteronism (HP:0000859) | 4.18966503 |
| 15 | Autoimmune thrombocytopenia (HP:0001973) | 4.11777610 |
| 16 | Pustule (HP:0200039) | 4.06799363 |
| 17 | Abdominal distention (HP:0003270) | 4.02377551 |
| 18 | Hemorrhage of the eye (HP:0011885) | 3.90994167 |
| 19 | Widely patent fontanelles and sutures (HP:0004492) | 3.90841177 |
| 20 | Chronic diarrhea (HP:0002028) | 3.69789314 |
| 21 | Gastrointestinal dysmotility (HP:0002579) | 3.60080547 |
| 22 | Fat malabsorption (HP:0002630) | 3.56408465 |
| 23 | Wide cranial sutures (HP:0010537) | 3.47904179 |
| 24 | Rectal prolapse (HP:0002035) | 3.35779793 |
| 25 | Systemic lupus erythematosus (HP:0002725) | 3.35010856 |
| 26 | Milia (HP:0001056) | 3.34612299 |
| 27 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 3.34146414 |
| 28 | Autoimmune hemolytic anemia (HP:0001890) | 3.18386128 |
| 29 | Poikilocytosis (HP:0004447) | 3.18224093 |
| 30 | Pigmentary retinal degeneration (HP:0001146) | 3.14289945 |
| 31 | Flat acetabular roof (HP:0003180) | 3.12480592 |
| 32 | Abnormality of vitamin B metabolism (HP:0004340) | 3.09852310 |
| 33 | Pili torti (HP:0003777) | 3.06002237 |
| 34 | Hyponatremia (HP:0002902) | 3.05866212 |
| 35 | Dehydration (HP:0001944) | 3.03163163 |
| 36 | Villous atrophy (HP:0011473) | 2.95902213 |
| 37 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.95902213 |
| 38 | Woolly hair (HP:0002224) | 2.95202095 |
| 39 | Congenital sensorineural hearing impairment (HP:0008527) | 2.94500008 |
| 40 | Ventricular fibrillation (HP:0001663) | 2.93005117 |
| 41 | Hyperkalemia (HP:0002153) | 2.92415382 |
| 42 | Hyperactive renin-angiotensin system (HP:0000841) | 2.90227445 |
| 43 | Hypokalemia (HP:0002900) | 2.90214475 |
| 44 | Abnormality of potassium homeostasis (HP:0011042) | 2.89379066 |
| 45 | Hypolipoproteinemia (HP:0010981) | 2.88472786 |
| 46 | Glycosuria (HP:0003076) | 2.85042785 |
| 47 | Abnormality of urine glucose concentration (HP:0011016) | 2.85042785 |
| 48 | Focal segmental glomerulosclerosis (HP:0000097) | 2.84989690 |
| 49 | Progressive hearing impairment (HP:0001730) | 2.78534770 |
| 50 | Abnormality of the 1st metacarpal (HP:0010009) | 2.77089553 |
| 51 | Abnormality of vitamin metabolism (HP:0100508) | 2.73314539 |
| 52 | Hyperammonemia (HP:0001987) | 2.72520221 |
| 53 | Syncope (HP:0001279) | 2.65520965 |
| 54 | Atrophic scars (HP:0001075) | 2.64490063 |
| 55 | Cerebral palsy (HP:0100021) | 2.63281235 |
| 56 | Intrahepatic cholestasis (HP:0001406) | 2.62956029 |
| 57 | Micronodular cirrhosis (HP:0001413) | 2.62947771 |
| 58 | Metabolic alkalosis (HP:0200114) | 2.62534113 |
| 59 | Cheilitis (HP:0100825) | 2.61934300 |
| 60 | Palpitations (HP:0001962) | 2.60663068 |
| 61 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.55883781 |
| 62 | Dicarboxylic aciduria (HP:0003215) | 2.55883781 |
| 63 | Hyperglycinuria (HP:0003108) | 2.52935463 |
| 64 | Ureteral stenosis (HP:0000071) | 2.51915491 |
| 65 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.51760267 |
| 66 | Abnormality of the gastric mucosa (HP:0004295) | 2.51022838 |
| 67 | Fragile nails (HP:0001808) | 2.49852741 |
| 68 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.45706624 |
| 69 | Abnormal tarsal ossification (HP:0008369) | 2.44631995 |
| 70 | Mesangial abnormality (HP:0001966) | 2.43531959 |
| 71 | Abnormality of chloride homeostasis (HP:0011422) | 2.41006085 |
| 72 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.40361153 |
| 73 | Abnormality of glycine metabolism (HP:0010895) | 2.40361153 |
| 74 | Abnormal biliary tract morphology (HP:0012440) | 2.39409365 |
| 75 | Alopecia of scalp (HP:0002293) | 2.39389446 |
| 76 | Hypotension (HP:0002615) | 2.39109245 |
| 77 | Complement deficiency (HP:0004431) | 2.38959917 |
| 78 | Glomerulosclerosis (HP:0000096) | 2.38714729 |
| 79 | Goiter (HP:0000853) | 2.36377942 |
| 80 | Potter facies (HP:0002009) | 2.34398127 |
| 81 | Facial shape deformation (HP:0011334) | 2.34398127 |
| 82 | Ureteral obstruction (HP:0006000) | 2.32696581 |
| 83 | Abnormality of the distal phalanx of the thumb (HP:0009617) | 2.32196056 |
| 84 | Confusion (HP:0001289) | 2.29398013 |
| 85 | Abnormality of complement system (HP:0005339) | 2.28637230 |
| 86 | Xanthomatosis (HP:0000991) | 2.26507867 |
| 87 | Fragile skin (HP:0001030) | 2.26406734 |
| 88 | Thin bony cortex (HP:0002753) | 2.26127503 |
| 89 | Increased IgE level (HP:0003212) | 2.25647010 |
| 90 | Glomerulonephritis (HP:0000099) | 2.24672711 |
| 91 | Abnormality of purine metabolism (HP:0004352) | 2.22955516 |
| 92 | Hyperparathyroidism (HP:0000843) | 2.22531863 |
| 93 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.22262681 |
| 94 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22158395 |
| 95 | Nephrolithiasis (HP:0000787) | 2.20967030 |
| 96 | Onycholysis (HP:0001806) | 2.20102421 |
| 97 | Increased purine levels (HP:0004368) | 2.18563645 |
| 98 | Hyperuricemia (HP:0002149) | 2.18563645 |
| 99 | Curly hair (HP:0002212) | 2.17964743 |
| 100 | Metabolic acidosis (HP:0001942) | 2.17803541 |
| 101 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.17282877 |
| 102 | Short phalanx of the thumb (HP:0009660) | 2.16858989 |
| 103 | Tongue fasciculations (HP:0001308) | 2.16409828 |
| 104 | Plantar hyperkeratosis (HP:0007556) | 2.16021930 |
| 105 | Abnormality of the nasal mucosa (HP:0000433) | 2.14598758 |
| 106 | Flattened epiphyses (HP:0003071) | 2.13610494 |
| 107 | Proximal tubulopathy (HP:0000114) | 2.13567001 |
| 108 | Abnormality of sodium homeostasis (HP:0010931) | 2.13554356 |
| 109 | Delayed CNS myelination (HP:0002188) | 2.13403546 |
| 110 | Late onset (HP:0003584) | 2.12756323 |
| 111 | Adrenal overactivity (HP:0002717) | 2.09575089 |
| 112 | Increased mean platelet volume (HP:0011877) | 2.08561465 |
| 113 | Hypercholesterolemia (HP:0003124) | 2.07707334 |
| 114 | Polycythemia (HP:0001901) | 2.07068891 |
| 115 | Cone-rod dystrophy (HP:0000548) | 2.07052458 |
| 116 | Eczematoid dermatitis (HP:0000976) | 2.06621817 |
| 117 | Abnormal hair laboratory examination (HP:0003328) | 2.05860001 |
| 118 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.04441166 |
| 119 | Abnormality of carpal bone ossification (HP:0006257) | 2.02931086 |
| 120 | Bundle branch block (HP:0011710) | 2.01874474 |
| 121 | Chronic bronchitis (HP:0004469) | 2.00961932 |
| 122 | Steatorrhea (HP:0002570) | 1.98414437 |
| 123 | Abnormality of nucleobase metabolism (HP:0010932) | 1.97383218 |
| 124 | Nephritis (HP:0000123) | 1.97146141 |
| 125 | Severe combined immunodeficiency (HP:0004430) | 1.96537980 |
| 126 | Combined immunodeficiency (HP:0005387) | 1.96157595 |
| 127 | Ventricular tachycardia (HP:0004756) | 1.95952639 |
| 128 | Abnormality of B cell number (HP:0010975) | 1.95728743 |
| 129 | B lymphocytopenia (HP:0010976) | 1.95728743 |
| 130 | Reticulocytosis (HP:0001923) | 1.94843495 |
| 131 | Progressive sensorineural hearing impairment (HP:0000408) | 1.93849265 |
| 132 | Hyperphosphaturia (HP:0003109) | 1.92124066 |
| 133 | Abnormal foot bone ossification (HP:0010675) | 1.91070856 |
| 134 | Abnormal glucose tolerance (HP:0001952) | 1.90352099 |
| 135 | Biliary tract neoplasm (HP:0100574) | 1.90070318 |
| 136 | Hypoalbuminemia (HP:0003073) | 1.89667045 |
| 137 | Abnormal albumin level (HP:0012116) | 1.89667045 |
| 138 | Prolonged QT interval (HP:0001657) | 1.89289706 |
| 139 | Muscle fibrillation (HP:0010546) | 1.87446473 |
| 140 | Abnormal hand bone ossification (HP:0010660) | 1.87434106 |
| 141 | Vascular calcification (HP:0004934) | 1.86073195 |
| 142 | Pancreatitis (HP:0001733) | 1.85055175 |
| 143 | Growth hormone excess (HP:0000845) | 1.83326641 |
| 144 | Hyperphosphatemia (HP:0002905) | 1.82134491 |
| 145 | Ankle clonus (HP:0011448) | 1.80079894 |
| 146 | Hypophosphatemia (HP:0002148) | 1.78811219 |
| 147 | Renal salt wasting (HP:0000127) | 1.76248035 |
| 148 | Nasal polyposis (HP:0100582) | 1.76117696 |
| 149 | Protuberant abdomen (HP:0001538) | 1.75605757 |
| 150 | Enlarged epiphyses (HP:0010580) | 1.75402222 |
| 151 | Chronic otitis media (HP:0000389) | 1.70894356 |
| 152 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.70737633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 5.92782681 |
| 2 | EIF2AK1 | 5.08189930 |
| 3 | LMTK2 | 4.87380158 |
| 4 | MST4 | 4.75081738 |
| 5 | ACVR1B | 4.58888830 |
| 6 | MST1R | 3.99142502 |
| 7 | NME1 | 3.28306665 |
| 8 | PRKG2 | 3.10059824 |
| 9 | MAP2K2 | 2.60643910 |
| 10 | MAP3K9 | 2.53360769 |
| 11 | GRK6 | 2.48950992 |
| 12 | MAP2K6 | 2.34906285 |
| 13 | EPHA2 | 2.17982382 |
| 14 | EPHB2 | 2.01812969 |
| 15 | PTK6 | 1.95861224 |
| 16 | WNK4 | 1.95368511 |
| 17 | PIK3CA | 1.89984430 |
| 18 | MAP3K2 | 1.75171255 |
| 19 | TLK1 | 1.73995620 |
| 20 | TESK1 | 1.70882296 |
| 21 | RIPK1 | 1.65513737 |
| 22 | EPHA3 | 1.61921633 |
| 23 | KSR2 | 1.60984005 |
| 24 | ERN1 | 1.58549496 |
| 25 | MAP3K10 | 1.52789618 |
| 26 | TAOK1 | 1.43606698 |
| 27 | AKT3 | 1.39948761 |
| 28 | ARAF | 1.36427852 |
| 29 | TTK | 1.35055443 |
| 30 | NUAK1 | 1.33366483 |
| 31 | IRAK1 | 1.28418839 |
| 32 | MET | 1.27693074 |
| 33 | TBK1 | 1.26826161 |
| 34 | STK10 | 1.13506101 |
| 35 | MYLK | 1.06740871 |
| 36 | MAP3K8 | 1.05772838 |
| 37 | TAOK3 | 1.01329295 |
| 38 | TESK2 | 0.95985559 |
| 39 | MAP2K1 | 0.93729394 |
| 40 | SIK1 | 0.90521295 |
| 41 | PRKCI | 0.88835549 |
| 42 | MAP3K13 | 0.85938970 |
| 43 | PTK2 | 0.82148821 |
| 44 | BLK | 0.81975622 |
| 45 | DDR2 | 0.80901983 |
| 46 | ERBB2 | 0.79337245 |
| 47 | LATS1 | 0.78531869 |
| 48 | RIPK4 | 0.77963620 |
| 49 | PBK | 0.71570498 |
| 50 | CAMK2D | 0.71356121 |
| 51 | MATK | 0.70810528 |
| 52 | PRKAA2 | 0.66019984 |
| 53 | TEC | 0.65084529 |
| 54 | FER | 0.63995101 |
| 55 | MAP3K1 | 0.63574207 |
| 56 | IRAK2 | 0.63311966 |
| 57 | FGFR3 | 0.63163878 |
| 58 | MAP4K1 | 0.63100874 |
| 59 | PDPK1 | 0.61671308 |
| 60 | EPHA4 | 0.60815217 |
| 61 | CASK | 0.60776527 |
| 62 | MAP3K11 | 0.60336754 |
| 63 | MAP3K7 | 0.58405638 |
| 64 | BRAF | 0.56402307 |
| 65 | PIM2 | 0.56136096 |
| 66 | EPHB1 | 0.55638986 |
| 67 | LIMK1 | 0.55535189 |
| 68 | ABL2 | 0.55327357 |
| 69 | TYK2 | 0.54498020 |
| 70 | PHKG2 | 0.54264556 |
| 71 | PHKG1 | 0.54264556 |
| 72 | CDC42BPA | 0.53454782 |
| 73 | ERBB4 | 0.52807644 |
| 74 | MAPK11 | 0.52777147 |
| 75 | FGFR4 | 0.50734090 |
| 76 | PAK4 | 0.49971989 |
| 77 | CHUK | 0.48675878 |
| 78 | AURKB | 0.47726980 |
| 79 | IKBKE | 0.47716664 |
| 80 | MAP3K14 | 0.47537686 |
| 81 | CAMK2B | 0.47399121 |
| 82 | DYRK1B | 0.47075109 |
| 83 | BMX | 0.45799639 |
| 84 | CAMK2G | 0.42620404 |
| 85 | RPS6KB2 | 0.42344602 |
| 86 | PAK1 | 0.40477084 |
| 87 | NLK | 0.39511316 |
| 88 | MELK | 0.39011910 |
| 89 | PRKCA | 0.38322892 |
| 90 | TNIK | 0.36530768 |
| 91 | MAP3K6 | 0.35075367 |
| 92 | PDK1 | 0.34715077 |
| 93 | PINK1 | 0.34441727 |
| 94 | STK24 | 0.33463424 |
| 95 | MAPKAPK2 | 0.32280296 |
| 96 | IKBKB | 0.31772763 |
| 97 | PRKCZ | 0.30885343 |
| 98 | PRKAA1 | 0.30780406 |
| 99 | CSK | 0.29853536 |
| 100 | EEF2K | 0.28407004 |
| 101 | SRC | 0.26676073 |
| 102 | MAP3K5 | 0.23853928 |
| 103 | IRAK4 | 0.23515150 |
| 104 | ADRBK2 | 0.23494209 |
| 105 | DMPK | 0.22556708 |
| 106 | ROCK1 | 0.21691225 |
| 107 | STK39 | 0.21585445 |
| 108 | PRKCQ | 0.20820441 |
| 109 | MAPKAPK3 | 0.20751191 |
| 110 | CSNK1A1 | 0.20268855 |
| 111 | MAP3K3 | 0.19868673 |
| 112 | LRRK2 | 0.19361035 |
| 113 | PAK3 | 0.19239860 |
| 114 | RAF1 | 0.19181935 |
| 115 | MAP3K12 | 0.19117687 |
| 116 | IGF1R | 0.18245431 |
| 117 | PRKACG | 0.17264012 |
| 118 | KSR1 | 0.17213010 |
| 119 | CDK19 | 0.16559144 |
| 120 | GRK1 | 0.16326872 |
| 121 | PDK2 | 0.15640704 |
| 122 | SCYL2 | 0.14878867 |
| 123 | DAPK2 | 0.14350799 |
| 124 | RET | 0.13889589 |
| 125 | OXSR1 | 0.13770785 |
| 126 | STK3 | 0.13375041 |
| 127 | IRAK3 | 0.13139125 |
| 128 | AKT2 | 0.12605630 |
| 129 | PRKCE | 0.12174383 |
| 130 | JAK1 | 0.11692687 |
| 131 | FYN | 0.11675195 |
| 132 | CSF1R | 0.11351683 |
| 133 | PRKCB | 0.10801043 |
| 134 | PRKCD | 0.10208950 |
| 135 | ZAP70 | 0.10086176 |
| 136 | CDK9 | 0.09952730 |
| 137 | PRPF4B | 0.09452899 |
| 138 | GRK5 | 0.08874254 |
| 139 | LYN | 0.07533885 |
| 140 | JAK2 | 0.07455911 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 5.75512049 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 4.79019116 |
| 3 | Mineral absorption_Homo sapiens_hsa04978 | 4.08961525 |
| 4 | Renin-angiotensin system_Homo sapiens_hsa04614 | 3.78383104 |
| 5 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 3.47166385 |
| 6 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.40105007 |
| 7 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.62631398 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 2.59843088 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 2.24525195 |
| 10 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 2.20981192 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.17946486 |
| 12 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 2.17568231 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.06011221 |
| 14 | Histidine metabolism_Homo sapiens_hsa00340 | 2.03974091 |
| 15 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.02896009 |
| 16 | Protein digestion and absorption_Homo sapiens_hsa04974 | 2.01650703 |
| 17 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.93708719 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.71218330 |
| 19 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.59919161 |
| 20 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.56345433 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.52795971 |
| 22 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47927679 |
| 23 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.47217880 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.38285844 |
| 25 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.35291431 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.32109995 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.29581056 |
| 28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.27092945 |
| 29 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22464885 |
| 30 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19985886 |
| 31 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.19588086 |
| 32 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.11356575 |
| 33 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 1.02455847 |
| 34 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.00593730 |
| 35 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.99209119 |
| 36 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97665160 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95835094 |
| 38 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94630779 |
| 39 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.94596661 |
| 40 | Sulfur relay system_Homo sapiens_hsa04122 | 0.93955167 |
| 41 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90165055 |
| 42 | Asthma_Homo sapiens_hsa05310 | 0.90063502 |
| 43 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85228298 |
| 44 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84954455 |
| 45 | Tight junction_Homo sapiens_hsa04530 | 0.84139974 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 0.82640758 |
| 47 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.81335889 |
| 48 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.77903159 |
| 49 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.77285706 |
| 50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.76015120 |
| 51 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.75560180 |
| 52 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74547977 |
| 53 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74166248 |
| 54 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.73075011 |
| 55 | Allograft rejection_Homo sapiens_hsa05330 | 0.72819605 |
| 56 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.69646196 |
| 57 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.68446223 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68033906 |
| 59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.67349418 |
| 60 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66803678 |
| 61 | Hepatitis C_Homo sapiens_hsa05160 | 0.66111535 |
| 62 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.65089235 |
| 63 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64294997 |
| 64 | Salmonella infection_Homo sapiens_hsa05132 | 0.63201697 |
| 65 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62966481 |
| 66 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.59378124 |
| 67 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.56858729 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56530355 |
| 69 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.56475875 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.54143083 |
| 71 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.53817293 |
| 72 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.52034563 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.50944653 |
| 74 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.47257829 |
| 75 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.45385853 |
| 76 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.45218693 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.44804835 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.44114382 |
| 79 | Salivary secretion_Homo sapiens_hsa04970 | 0.43739276 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.42480234 |
| 81 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.42043827 |
| 82 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.41401117 |
| 83 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.39227276 |
| 84 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38999964 |
| 85 | Adherens junction_Homo sapiens_hsa04520 | 0.38862652 |
| 86 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37232962 |
| 87 | Parkinsons disease_Homo sapiens_hsa05012 | 0.35137808 |
| 88 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.34749776 |
| 89 | Insulin resistance_Homo sapiens_hsa04931 | 0.34564636 |
| 90 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33771898 |
| 91 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.32238661 |
| 92 | Bladder cancer_Homo sapiens_hsa05219 | 0.31874661 |
| 93 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.31606417 |
| 94 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.31584180 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.29662232 |
| 96 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.29479409 |
| 97 | Influenza A_Homo sapiens_hsa05164 | 0.29009206 |
| 98 | Pertussis_Homo sapiens_hsa05133 | 0.28790804 |
| 99 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28758037 |
| 100 | Renin secretion_Homo sapiens_hsa04924 | 0.27024314 |
| 101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.26620999 |
| 102 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.25633477 |
| 103 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.21841144 |
| 104 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21340745 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.20999545 |
| 106 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.20028767 |
| 107 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.19959640 |
| 108 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.19790956 |
| 109 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.18638312 |
| 110 | Insulin secretion_Homo sapiens_hsa04911 | 0.18042315 |
| 111 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.16977053 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.14720192 |
| 113 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.14689896 |
| 114 | Huntingtons disease_Homo sapiens_hsa05016 | 0.14326246 |
| 115 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.13309395 |
| 116 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.12357437 |
| 117 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.11311526 |
| 118 | Leishmaniasis_Homo sapiens_hsa05140 | 0.10905219 |
| 119 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.09902616 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.09528296 |
| 121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.09459024 |
| 122 | Peroxisome_Homo sapiens_hsa04146 | 0.09193087 |
| 123 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.07552112 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.06758273 |
| 125 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.06698871 |
| 126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.05492119 |
| 127 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0156535 |

